No Effect of Anti-Interleukin-5 Therapy (Mepolizumab) on the Atopy Patch Test in Atopic Dermatitis Patients

Publisher： Karger

E-ISSN： 1423-0097|141|3|290-294

ISSN： 1018-2438

Source： International Archives of Allergy and Immunology, Vol.141, Iss.3, 2006-10, pp. : 290-294

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Atopy patch test with house dust mite in Chinese patients with atopic dermatitis

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 30, Iss. 9, 2016-09 ,pp. : 1522-1526

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anti‐Interleukin Therapy in Asthma

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 1, 2015-01 ,pp. : 55-65

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anti‐interleukin‐6 signalling therapy rebalances the disrupted cytokine production of B cells from patients with active rheumatoid arthritis

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 48, Iss. 1, 2018-01 ,pp. : 194-203

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interleukin-18 Is Elevated in the Sera from Patients with Atopic Dermatitis and from Atopic Dermatitis Model Mice, NC/Nga

By  

International Archives of Allergy and Immunology, Vol. 125, Iss. 3, 2001-08 ,pp. : 236-240

Karger

Access to resources Recommend Favorite

Leukoderma in patients with atopic dermatitis

By  

THE JOURNAL OF DERMATOLOGY, Vol. 42, Iss. 2, 2015-02 ,pp. : 215-218

John Wiley & Sons Inc

Access to resources Recommend Favorite